rs10987768

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_024642.5(GALNT12):​c.136G>A​(p.Gly46Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0209 in 1,018,778 control chromosomes in the GnomAD database, including 685 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G46E) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.034 ( 267 hom., cov: 32)
Exomes 𝑓: 0.019 ( 418 hom. )

Consequence

GALNT12
NM_024642.5 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.840

Publications

7 publications found
Variant links:
Genes affected
GALNT12 (HGNC:19877): (polypeptide N-acetylgalactosaminyltransferase 12) This gene encodes a member of a family of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases, which catalyze the transfer of N-acetylgalactosamine (GalNAc) from UDP-GalNAc to a serine or threonine residue on a polypeptide acceptor in the initial step of O-linked protein glycosylation. Mutations in this gene are associated with an increased susceptibility to colorectal cancer.[provided by RefSeq, Mar 2011]
GALNT12 Gene-Disease associations (from GenCC):
  • colorectal cancer, susceptibility to, 1
    Inheritance: Unknown, AD Classification: LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_024642.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0016487539).
BP6
Variant 9-98807834-G-A is Benign according to our data. Variant chr9-98807834-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 485632.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.177 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_024642.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GALNT12
NM_024642.5
MANE Select
c.136G>Ap.Gly46Arg
missense
Exon 1 of 10NP_078918.3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GALNT12
ENST00000375011.4
TSL:1 MANE Select
c.136G>Ap.Gly46Arg
missense
Exon 1 of 10ENSP00000364150.3Q8IXK2-1
GALNT12
ENST00000969913.1
c.136G>Ap.Gly46Arg
missense
Exon 1 of 11ENSP00000639972.1
GALNT12
ENST00000969912.1
c.136G>Ap.Gly46Arg
missense
Exon 1 of 11ENSP00000639971.1

Frequencies

GnomAD3 genomes
AF:
0.0344
AC:
5054
AN:
146900
Hom.:
263
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00494
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0803
Gnomad ASJ
AF:
0.0124
Gnomad EAS
AF:
0.187
Gnomad SAS
AF:
0.0918
Gnomad FIN
AF:
0.113
Gnomad MID
AF:
0.00321
Gnomad NFE
AF:
0.0180
Gnomad OTH
AF:
0.0347
GnomAD2 exomes
AF:
0.0192
AC:
1
AN:
52
AF XY:
0.00
show subpopulations
Gnomad NFE exome
AF:
0.0227
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0186
AC:
16223
AN:
871770
Hom.:
418
Cov.:
30
AF XY:
0.0185
AC XY:
7539
AN XY:
406522
show subpopulations
African (AFR)
AF:
0.00266
AC:
44
AN:
16554
American (AMR)
AF:
0.132
AC:
295
AN:
2236
Ashkenazi Jewish (ASJ)
AF:
0.0121
AC:
74
AN:
6128
East Asian (EAS)
AF:
0.219
AC:
1240
AN:
5668
South Asian (SAS)
AF:
0.0776
AC:
1368
AN:
17640
European-Finnish (FIN)
AF:
0.124
AC:
508
AN:
4108
Middle Eastern (MID)
AF:
0.00950
AC:
17
AN:
1790
European-Non Finnish (NFE)
AF:
0.0149
AC:
11723
AN:
788144
Other (OTH)
AF:
0.0323
AC:
954
AN:
29502
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
928
1856
2783
3711
4639
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
630
1260
1890
2520
3150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0344
AC:
5058
AN:
147008
Hom.:
267
Cov.:
32
AF XY:
0.0415
AC XY:
2972
AN XY:
71570
show subpopulations
African (AFR)
AF:
0.00492
AC:
202
AN:
41040
American (AMR)
AF:
0.0810
AC:
1197
AN:
14784
Ashkenazi Jewish (ASJ)
AF:
0.0124
AC:
42
AN:
3392
East Asian (EAS)
AF:
0.187
AC:
947
AN:
5060
South Asian (SAS)
AF:
0.0910
AC:
438
AN:
4812
European-Finnish (FIN)
AF:
0.113
AC:
975
AN:
8656
Middle Eastern (MID)
AF:
0.00345
AC:
1
AN:
290
European-Non Finnish (NFE)
AF:
0.0180
AC:
1188
AN:
66024
Other (OTH)
AF:
0.0333
AC:
68
AN:
2042
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
230
460
690
920
1150
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
56
112
168
224
280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0294
Hom.:
15
Bravo
AF:
0.0335
Asia WGS
AF:
0.143
AC:
395
AN:
2760

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
1
Colorectal cancer, susceptibility to, 1 (1)
-
-
1
GALNT12-related disorder (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.69
T
BayesDel_noAF
Benign
-0.62
CADD
Benign
4.3
DANN
Benign
0.88
DEOGEN2
Benign
0.012
T
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.031
N
LIST_S2
Benign
0.34
T
MetaRNN
Benign
0.0016
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
N
PhyloP100
-0.84
PrimateAI
Pathogenic
0.86
D
PROVEAN
Benign
0.93
N
REVEL
Benign
0.064
Sift
Benign
0.25
T
Sift4G
Benign
0.41
T
PromoterAI
-0.052
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Varity_R
0.040
gMVP
0.41
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs10987768;
hg19: chr9-101570116;
COSMIC: COSV105317555;
COSMIC: COSV105317555;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.